CS logo
small CS logo
Tobacco Use Research Center

Philadelphia, Pennsylvania, United States

About Tobacco Use Research Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Tobacco Use Research Center


During the past decade, Tobacco Use Research Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Tobacco Use Research Center" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Tobacco Use Research Center


According to Clinical.Site data, the most researched conditions in "Tobacco Use Research Center" are "Nicotine Dependence" (2 trials), "Nicotine Addiction" (1 trials), "TOBACCO USE CESSATION" (1 trials), "Tobacco Dependence" (1 trials) and "Tobacco Use Disorder" (1 trials). Many other conditions were trialed in "Tobacco Use Research Center" in a lesser frequency.

Clinical Trials Intervention Types at Tobacco Use Research Center


Most popular intervention types in "Tobacco Use Research Center" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Varenicline" (2 trials), "24-weeks of nicotine patch" (1 trials), "Galantamine ER" (1 trials) and "Naltrexone" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Tobacco Use Research Center


The vast majority of trials in "Tobacco Use Research Center" are 6 trials for "All" genders.

Clinical Trials Status at Tobacco Use Research Center


Currently, there are NaN active trials in "Tobacco Use Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Tobacco Use Research Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tobacco Use Research Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".